什么是邏輯

進(jìn)城

Abstract
PIP: Ministers from the countries of the Non-Aligned Movement (NAM) got together at the Ministerial Meeting on Population in Bali, Indonesia, November 11-13, 1993, to develop the Denpasar Declaration on Population and Development. The declaration was made with full consideration and acceptance of the sovereignty of individual nations and the decisions on population of the heads of states and governments at the tenth conference of Non-Aligned Countries at Jakarta, 1992, and the results of the meeting of the Standing Ministerial Committee for Economic Cooperation of the NAM in Bali 1993. The ministers recognize that population should be an integral part of the development process, population policies and development efforts should be designed to improve the quality of life for present generations without compromising the ability of future generations to meet their own needs, and the alleviation of poverty is essential to the dignity of humankind and fundamental to the achievement of sustainable development. They further reaffirm the existence of humans as the center of concern for sustainable development, the right to an adequate standard of living for all, gender equality, greater multilateral cooperation for development, and that all developing countries should participate effectively at the International Conference on Population and Development to be convened in Cairo in 1994. The text of the declaration is included.

PubMed Disclaimer

進(jìn)城

不知道寫的這些非中文的話與要說明的經(jīng)脈有何關(guān)系？

進(jìn)城

進(jìn)城 發(fā)表于 2025-7-11 01:58
Abstract
PIP: Ministers from the countries of the Non-Aligned Movement (NAM) got together at the Mi ...

摘要
1993 年 11 月 11 日至 13 日，不結(jié)盟運(yùn)動(dòng)各國部長在印度尼西亞巴厘島舉行的人口問題部長級(jí)會(huì)議上匯聚一堂，共同制定了《關(guān)于人口與發(fā)展的登巴薩宣言》。該宣言充分考慮并認(rèn)可了各國主權(quán)，以及 1992 年在雅加達(dá)舉行的第十次不結(jié)盟國家首腦會(huì)議上各國國家元首和政府首腦就人口問題所做的決定，還有 1993 年在巴厘島舉行的不結(jié)盟運(yùn)動(dòng)經(jīng)濟(jì)合作部長級(jí)常設(shè)委員會(huì)會(huì)議的成果。部長們認(rèn)識(shí)到，人口應(yīng)成為發(fā)展進(jìn)程不可或缺的一部分，制定人口政策和開展發(fā)展工作，應(yīng)旨在提高當(dāng)代人的生活質(zhì)量，同時(shí)又不損害子孫后代滿足自身需求的能力，而且減輕貧困對(duì)于人類尊嚴(yán)至關(guān)重要，是實(shí)現(xiàn)可持續(xù)發(fā)展的根本所在。他們進(jìn)一步重申，人類是可持續(xù)發(fā)展關(guān)注的核心，人人享有適足生活水準(zhǔn)的權(quán)利、性別平等、加強(qiáng)多邊合作促進(jìn)發(fā)展，以及所有發(fā)展中國家都應(yīng)切實(shí)參與 1994 年將在開羅召開的國際人口與發(fā)展會(huì)議。宣言全文如下。

進(jìn)城

Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer
Arun Sharma 1, Stephen M Schwartz, Eduardo Méndez
Affiliations expand
PMID: 23456789 PMCID: PMC6121709 DOI: 10.1002/cncr.27976
Abstract
Background: Given the complexity of management of advanced head and neck squamous cell carcinoma (HNSCC), this study hypothesized that high hospital volume would be associated with receiving National Comprehensive Cancer Network (NCCN) guideline therapy and improved survival in patients with advanced HNSCC.

Methods: The Surveillance, Epidemiology, and End Results (SEER)-Medicare database was used to identify patients with advanced HNSCC. Treatment modalities and survival were determined using Medicare data. Hospital volume was determined by the number of patients with HNSCC treated at each hospital.

Results: There were 1195 patients with advanced HNSCC who met inclusion criteria. In multivariable analyses, high hospital volume was not associated with receiving multimodality therapy per NCCN guidelines (odds ratio = 1.02, 95% confidence interval = 0.66-1.60), but showed a nearly significant inverse association with survival in a model adjusted for National Cancer Institute-designated cancer center status, age, sex, race, socioeconomic status, marital status, comorbidity, year of diagnosis, tumor site, and tumor stage (hazard ratio = 0.85, 95% confidence interval = 0.69-1.04).

Conclusions: Medicare patients with advanced HNSCC treated at high-volume hospitals were not more likely to receive NCCN guideline therapy, but had nearly statistically significant better survival, when compared with patients treated at low-volume hospitals. These results suggest that features of high-volume hospitals other than delivery of NCCN guideline therapy influence survival. Cancer 2013. © 2013 American Cancer Society.

Copyright © 2013 American Cancer Society.

PubMed Disclaimer

Conflict of interest statement
CONFLICT OF INTEREST DISCLOSURE

Dr. Méndez has received speaking fees/honoraria from Intuitive Surgical, Inc. All other authors made no disclosures.

進(jìn)城

進(jìn)城 發(fā)表于 2025-7-11 02:03
Hospital volume is associated with survival but not multimodality therapy in Medicare patients with  ...

醫(yī)院規(guī)模與老年醫(yī)保（Medicare）晚期頭頸癌患者的生存情況相關(guān)，但與多模式治療無關(guān)
阿倫・夏爾馬 1，斯蒂芬・M・施瓦茨，愛德華多・門德斯
所屬機(jī)構(gòu)展開
PMID：23456789 PMCID：PMC6121709 DOI：10.1002/cncr.27976
摘要
背景：鑒于晚期頭頸部鱗狀細(xì)胞癌（HNSCC）管理的復(fù)雜性，本研究假設(shè)，在晚期 HNSCC 患者中，醫(yī)院規(guī)模大與接受美國國家綜合癌癥網(wǎng)絡(luò)（NCCN）指南治療及生存改善相關(guān)。
方法：利用監(jiān)測、流行病學(xué)和最終結(jié)果（SEER） - 老年醫(yī)保（Medicare）數(shù)據(jù)庫確定晚期 HNSCC 患者。使用老年醫(yī)保（Medicare）數(shù)據(jù)確定治療方式和生存情況。醫(yī)院規(guī)模由每家醫(yī)院治療的 HNSCC 患者數(shù)量決定。
結(jié)果：有 1195 例晚期 HNSCC 患者符合納入標(biāo)準(zhǔn)。在多變量分析中，醫(yī)院規(guī)模大與按照 NCCN 指南接受多模式治療無關(guān)（優(yōu)勢比 = 1.02，95% 置信區(qū)間 = 0.66 - 1.60），但在針對(duì)美國國家癌癥研究所指定的癌癥中心狀態(tài)、年齡、性別、種族、社會(huì)經(jīng)濟(jì)狀況、婚姻狀況、合并癥、診斷年份、腫瘤部位和腫瘤分期進(jìn)行調(diào)整的模型中，與生存情況呈近乎顯著的負(fù)相關(guān)（風(fēng)險(xiǎn)比 = 0.85，95% 置信區(qū)間 = 0.69 - 1.04）。
結(jié)論：與在小規(guī)模醫(yī)院接受治療的患者相比，在大規(guī)模醫(yī)院接受治療的老年醫(yī)保（Medicare）晚期 HNSCC 患者接受 NCCN 指南治療的可能性并不會(huì)更高，但生存情況在統(tǒng)計(jì)學(xué)上有近乎顯著的改善。這些結(jié)果表明，除了實(shí)施 NCCN 指南治療之外，大規(guī)模醫(yī)院的其他特征也會(huì)影響生存情況。《癌癥》2013 年。© 2013 美國癌癥協(xié)會(huì)。
版權(quán)所有 © 2013 美國癌癥協(xié)會(huì)。
PubMed 免責(zé)聲明
利益沖突聲明
利益沖突披露
門德斯博士從直覺外科公司（Intuitive Surgical, Inc.）獲得了演講費(fèi) / 酬金。其他所有作者均無利益沖突披露。

進(jìn)城

進(jìn)城 發(fā)表于 2025-7-11 02:04
醫(yī)院規(guī)模與老年醫(yī)保（Medicare）晚期頭頸癌患者的生存情況相關(guān)，但與多模式治療無關(guān)
阿倫・夏爾馬 ...

？

進(jìn)城

進(jìn)城 發(fā)表于 2025-7-11 02:02
摘要
1993 年 11 月 11 日至 13 日，不結(jié)盟運(yùn)動(dòng)各國部長在印度尼西亞巴厘島舉行的人口問題部長級(jí)會(huì)議上 ...

？

進(jìn)城

2. **獨(dú)立于已知結(jié)構(gòu)的物質(zhì)證據(jù)**（如新細(xì)胞類型或信號(hào)分子）。

進(jìn)城

進(jìn)城 發(fā)表于 2025-7-11 02:11
2. **獨(dú)立于已知結(jié)構(gòu)的物質(zhì)證據(jù)**（如新細(xì)胞類型或信號(hào)分子）。

經(jīng)絡(luò)不是什么組織學(xué)不理解成是宏觀的管道管腔類的組織結(jié)構(gòu)。

經(jīng)脈是由經(jīng)脈細(xì)胞的雙層膜之間的空間和細(xì)胞表面蛋白質(zhì)分子在構(gòu)象門組成的。
經(jīng)氣或氣體由細(xì)胞表面的蛋白質(zhì)構(gòu)象門的開放進(jìn)入到細(xì)胞層內(nèi)，但是并不深入到細(xì)胞內(nèi)。
這與一般有構(gòu)象門或構(gòu)象通道不同，生理學(xué)的構(gòu)象門或通道是有將人體生理分子運(yùn)進(jìn)細(xì)胞內(nèi)和將合成的蛋白質(zhì)分子之類的物質(zhì)再從細(xì)胞內(nèi)胞吐胞吞至細(xì)胞外。

進(jìn)城

（如新細(xì)胞類型或信號(hào)分子）。


經(jīng)脈中流動(dòng)的氣體C2H6NO分子本身不是有生理信號(hào)功能作用的物質(zhì)，是對(duì)信號(hào)分子有加工作用的一類氣體分子。